These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 8434967)
1. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]. Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967 [TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]. Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392 [TBL] [Abstract][Full Text] [Related]
3. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]. Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340 [TBL] [Abstract][Full Text] [Related]
4. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level]. Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D Gan To Kagaku Ryoho; 1993 Feb; 20(2):271-7. PubMed ID: 8434966 [TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer]. Ito K; Udagawa Y; Nozawa S Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between tumor markers and clinical symptoms in ovarian cancer]. Yakushiji M; Nishimura H Rinsho Byori; 1992 Apr; 40(4):354-8. PubMed ID: 1593760 [TBL] [Abstract][Full Text] [Related]
7. [Clinical value of a new serum tumor marker CA602 in ovarian cancers]. Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group]. Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400 [TBL] [Abstract][Full Text] [Related]
10. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase. Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678 [TBL] [Abstract][Full Text] [Related]
11. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289 [TBL] [Abstract][Full Text] [Related]
12. CA54/61 as a marker for epithelial ovarian cancer. Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of a newly developed ovarian tumour marker, galactosyltransferase associated with tumour (GAT). Udagawa Y; Aoki D; Ito K; Uejima T; Uemura M; Nozawa S Eur J Cancer; 1998 Mar; 34(4):489-95. PubMed ID: 9713298 [TBL] [Abstract][Full Text] [Related]
14. [Application of monoclonal antibody OC 125 in gynecological oncology]. Wu AR; Wang EY; Wang XX; Jia XH; Li L Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653 [TBL] [Abstract][Full Text] [Related]
15. [Primary research on saliva and serum CA125 assays for detecting malignant ovarian tumors]. Chen DX; Li FQ Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):84-5, 123-4. PubMed ID: 2364796 [TBL] [Abstract][Full Text] [Related]
16. [The usefulness and limitation of sugar antigen in ovarian cancers--with special reference to a new tumor marker, CA54/61]. Nozawa S Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1147-51. PubMed ID: 2499263 [TBL] [Abstract][Full Text] [Related]
17. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers]. Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016 [TBL] [Abstract][Full Text] [Related]
18. [A clinical evaluation of the CA 72-4 serum level as a possible tumor marker]. Jibiki K; Takeda M; Abe H; Ito M; Odagiri E; Demura R; Demura H; Takizawa K Gan No Rinsho; 1990 Oct; 36(12):2146-52. PubMed ID: 2232183 [TBL] [Abstract][Full Text] [Related]
19. [Tumor markers of ovarian cancer]. Nozawa S Rinsho Byori; 1992 Apr; 40(4):349-53. PubMed ID: 1593759 [TBL] [Abstract][Full Text] [Related]
20. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes]. Nozawa S; Yajima M; Udagawa Y; Kiguchi K; Iizuka R; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1823-9. PubMed ID: 2687409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]